The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Journal: Evidence-based Cardiology. 2017;10(1): 22‑25

Read: 1672 times

To cite this article:

. Evidence-based Cardiology. 2017;10(1):22‑25. (In Russ.)

References:

  1. Gimbel J.R., Kanal E. Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J Am Coll Cardiol 2004;43:1325—1327.
  2. Cohen J.D., Costa H.S., Russo R.J. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol 2012;110:1631—1636.
  3. Gimbel J.R., Wilkoff B.L., Kanal E., Rozner M.A. Safe, sensible, sagacious: responsible scanning of pacemaker patients. Eur Heart J 2005;26:1683—1684.
  4. Sommer T., Naehle C.P., Schild H. Magnetic resonance imaging in patients with cardiac pacemakers. J Am Coll Cardiol 2005;46:561—562.
  5. Martin E.T., Coman J.A., Shellock F.G., et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315—1324.
  6. Sommer T., Naehle C.P., Yang A., et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285—1292.
  7. Nazarian S., Roguin A., Zviman M.M., et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006;114:1277—1284.
  8. Naehle C.P., Strach K., Thomas D., et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549—555.
  9. 9.Irnich W. Risks to pacemaker patients undergoing magnetic resonance imaging examinations. Europace 2010;12:918—920.
  10. 10.Gimbel J.R. Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a ‘modern’ pacemaker. Europace 2009;11:1241—1242.
  11. 11.Anfinsen O.G., Berntsen R.F., Aass H., et al. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002;25:1400—1402.
  12. 12.Gimbel J.R., Bailey S.M., Tchou P.J., et al. Strategies for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005;28:1041—1046.
  13. 13.Mollerus M., Albin G., Lipinski M., Lucca J. Cardiac biomarkers in patients with permanent PMs and ICDs undergoing an MR scan. Pacing Clin Electrophysiol 2008;31:1241—1245.
  14. 14.Boilson B.A., Wokhlu A., Acker N.G., et al. Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach. J Interv Card Electrophysiol 2012;33:59—67.
  15. 15.Burke P.T., Ghanbari H., Alexander P.B., et al. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010;28:59—66.
  16. Verma A., Ha A.C., Dennie C., et al. Canadian Heart Rhythm Society and Canadian Association of Radiologists consensus statement on magnetic resonance imaging with cardiac implantable electronic devices. Can J Cardiol 2014;30:1131—1141.
  17. Blomström Lundqvist C., Auricchio A., Brugada J., et al. The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology. Europace 2013;15:927—936.
  18. Nazarian S., Hansford R., Roguin A., et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011;155:415—424.
  19. Poole J.E., Gleva M.J., Mela T., et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation 2010;122:1553—1561.
  20. Hauser R.G., Katsiyiannis W.T., Gornick C.C., et al. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction. Europace 2010;12:395—401.
  21. Jones S.O. IV, Eckart R.E., Albert C.M., Epstein L.M. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm 2008;5:520—525.
  22. Wazni O., Epstein L.M., Carrillo R.G., et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol 2010;55:579—586.
  23. Wilkoff B.L., Byrd C.L., Love C.J., et al. Pacemaker lead extraction with the laser sheath: results of the Pacing Lead Extraction with the Excimer Sheath (PLEXES) trial. J Am Coll Cardiol 1999;33:1671—1676.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.